Jonas Leichsenring

2.0k total citations
32 papers, 833 citations indexed

About

Jonas Leichsenring is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jonas Leichsenring has authored 32 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jonas Leichsenring's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (6 papers) and Genetic factors in colorectal cancer (4 papers). Jonas Leichsenring is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (6 papers) and Genetic factors in colorectal cancer (4 papers). Jonas Leichsenring collaborates with scholars based in Germany, United States and France. Jonas Leichsenring's co-authors include Albrecht Stenzinger, Volker Endris, Martina Kirchner, Peter Schirmacher, Anna‐Lena Volckmar, Roland Penzel, Jan Budczies, Olaf Neumann, Michael Allgäuer and Stefan Fröhling and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Jonas Leichsenring

30 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Leichsenring Germany 16 486 405 348 205 145 32 833
Amélie Boichard United States 15 550 1.1× 310 0.8× 308 0.9× 311 1.5× 133 0.9× 25 1.0k
Janice F. Eakle United States 9 565 1.2× 345 0.9× 265 0.8× 246 1.2× 76 0.5× 22 805
Yasir Y. Elamin United States 16 595 1.2× 518 1.3× 164 0.5× 284 1.4× 87 0.6× 68 968
Leticia Varella United States 9 798 1.6× 446 1.1× 754 2.2× 259 1.3× 212 1.5× 20 1.3k
Hyesil Seol South Korea 15 480 1.0× 244 0.6× 307 0.9× 264 1.3× 123 0.8× 34 853
Chikako Shimizu Japan 17 626 1.3× 166 0.4× 484 1.4× 157 0.8× 205 1.4× 53 975
Céline Charon‐Barra France 14 392 0.8× 208 0.5× 222 0.6× 190 0.9× 237 1.6× 30 753
Daygen L. Finch Canada 15 447 0.9× 880 2.2× 444 1.3× 335 1.6× 166 1.1× 36 1.2k
Seung Eun Lee South Korea 19 475 1.0× 545 1.3× 239 0.7× 310 1.5× 177 1.2× 46 1.0k
Antonio Durando Italy 16 516 1.1× 158 0.4× 509 1.5× 318 1.6× 137 0.9× 42 976

Countries citing papers authored by Jonas Leichsenring

Since Specialization
Citations

This map shows the geographic impact of Jonas Leichsenring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Leichsenring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Leichsenring more than expected).

Fields of papers citing papers by Jonas Leichsenring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Leichsenring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Leichsenring. The network helps show where Jonas Leichsenring may publish in the future.

Co-authorship network of co-authors of Jonas Leichsenring

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Leichsenring. A scholar is included among the top collaborators of Jonas Leichsenring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Leichsenring. Jonas Leichsenring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jank, Paul, Jonas Leichsenring, Inga Hoffmann, et al.. (2023). High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma. Journal of Ovarian Research. 16(1). 150–150. 5 indexed citations
2.
Veinalde, Rūta, Gemma Pidelaserra-Martí, Chin Leng Tan, et al.. (2023). Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Frontiers in Immunology. 13. 1096162–1096162. 5 indexed citations
3.
Leichsenring, Jonas, Christine Solbach, Thomas Karn, et al.. (2022). EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy. BMC Cancer. 22(1). 1040–1040.
4.
Bochtler, Tilmann, Volker Endris, Thomas Hielscher, et al.. (2020). Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International Journal of Cancer. 146(11). 3053–3064. 10 indexed citations
5.
Bochtler, Tilmann, Volker Endris, Jonas Leichsenring, et al.. (2019). Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome. International Journal of Cancer. 145(11). 2963–2973. 20 indexed citations
6.
Kratochwil, Clemens, Frederik L. Giesel, Claus Peter Heußel, et al.. (2019). Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair–Associated Genes. Journal of Nuclear Medicine. 61(5). 683–688. 69 indexed citations
7.
Leichsenring, Jonas, et al.. (2019). Intravenous pyogenic granuloma of the renal vein: A rare morphological differential diagnosis to renal cell carcinoma. Urology Case Reports. 26. 100951–100951. 2 indexed citations
9.
Görtz, Magdalena, Jan Philipp Radtke, Gencay Hatiboglu, et al.. (2019). The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. European Urology Focus. 7(2). 325–331. 41 indexed citations
10.
Buchhalter, Ivo, Eugen Rempel, Volker Endris, et al.. (2018). Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis. International Journal of Cancer. 144(4). 848–858. 117 indexed citations
12.
Allgäuer, Michael, Jan Budczies, Petros Christopoulos, et al.. (2018). Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians. Translational Lung Cancer Research. 7(5). 703–715. 138 indexed citations
13.
Kriegsmann, Mark, Katharina Kriegsmann, Alexander Harms, et al.. (2018). Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer. Diagnostic Pathology. 13(1). 68–68. 7 indexed citations
14.
Leichsenring, Jonas, Anna‐Lena Volckmar, Martina Kirchner, et al.. (2017). Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Genes Chromosomes and Cancer. 57(2). 70–79. 13 indexed citations
15.
Pfarr, Nicole, Silvia Darb‐Esfahani, Jonas Leichsenring, et al.. (2017). Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology. Genes Chromosomes and Cancer. 56(10). 758–766. 16 indexed citations
16.
Kirchner, Martina, Dimitrije Brašanac, Jonas Leichsenring, et al.. (2017). Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas. Pathology. 50(3). 327–332. 24 indexed citations
17.
Pfarr, Nicole, Roland Penzel, Volker Endris, et al.. (2016). Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance. Genes Chromosomes and Cancer. 56(4). 255–265. 16 indexed citations
18.
Volckmar, Anna‐Lena, Volker Endris, Farastuk Bozorgmehr, et al.. (2016). Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report. Diagnostic Pathology. 11(1). 133–133. 6 indexed citations
19.
Leichsenring, Jonas, Anna‐Lena Volckmar, Roland Penzel, et al.. (2016). Synonymous EGFR variant p.Q787Q is neither prognostic nor predictive in patients with lung adenocarcinoma. Genes Chromosomes and Cancer. 56(3). 214–220. 8 indexed citations
20.
Volckmar, Anna‐Lena, Jonas Leichsenring, Christa Flechtenmacher, et al.. (2016). Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K–AKT pathway. Genes Chromosomes and Cancer. 56(1). 11–17. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026